APO-ACETAMINOPHEN CAPLETS
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-ACETAMINOPHEN CAPLETS in Canada?
Yes. APO-ACETAMINOPHEN CAPLETS 325MG has an active shortage reported to Health Canada (last updated October 2, 2026).
Why is APO-ACETAMINOPHEN CAPLETS not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-ACETAMINOPHEN CAPLETS be available again?
The manufacturer's estimated resolution date is December 11, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Cold and Flu Medication Shortages in Canada: What to Know
Why cold and flu products run short seasonally in Canada, how OTC shortages differ from prescription ones, and what to do if a product is out of stock.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ACETAMINOPHENE 325 TAB
DUCHESNAY INC
ACETAMINOPHEN TABLETS 325 MG
LABORATOIRES TRIANON INC.
ACETAMINOPHEN TAB 325MG
PHARMEL INC
NOVO-GESIC
TEVA CANADA LIMITED
Other Products
ACETAMINOPHEN TABLETS 500 MG
LABORATOIRES TRIANON INC.
ACETAMINOPHEN TAB EXTRA STRENGTH 500MG
DRUG TRADING COMPANY LTD.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-12-11
~2 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02229873
Strength
325MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ACETAMINOPHEN
Tier
Unrated
Last Updated
2026-10-02
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178